Immunohistochemistry (IHC) Market to Reach $3 Billion by 2025 - Shift in Focus on Value-based Healthcare Solutions - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Immunohistochemistry (IHC) Market, 2014-2025" report to their offering.

The global immunohistochemistry (IHC) market is estimated to reach a value of USD 3.1 billion by 2025. The rising prevalence of cancer and increasing healthcare expenses driven by expanding aging population base are recognized to be the most influential factors driving the growth of the immunohistochemistry market. Furthermore, the rapid growth of biotech industry highlighted by increase in growth and revenue coupled with increase in stock market capitalization will nurture the growth.

Cancer has high morbidity and mortality risk associated with them. The diagnosis of the disease is majorly dependent on the stage of the disease at admission. This has led to the high demand of immunohistochemistry products. IHC staining process is performed on cancer tissues to reveal the presence of HER2 receptors and/or hormone receptors on their surface. This information plays a vital role in planning the treatment for the disease, creating a demand for immunohistochemistry products. In addition, the rising popularity of targeted immunotherapy and biologic therapy for anticancer drug development and the increasing approvals of the same by the FDA to treat specific types of cancer are expected to benefit the growth in the long run.

Other important factors driving growth include the alarming rise in healthcare spending and the shift in focus on value-based healthcare solutions. In 2015, the U.S. healthcare spending witnessed an increase of 5.8% to reach a value of USD 3.2 trillion. To curb the issue and establish a more value-based healthcare delivery, hospitals and care facilities are adopting a more specific and targeted therapy for better outcomes.

Companies Mentioned

  • CMR Naviscan Corporation
  • Abcam plc
  • Agilent Technologies, Inc.
  • Bio SB Inc.
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Merck Millipore
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific Inc

Key Topics Covered:

1. Methodology and Scope

2. Executive Summary

3. Immunohistochemistry Market Variables, Trends & Scope

4. Immunohistochemistry: Product Estimates & Trend Analysis

5. Immunohistochemistry: Application Estimates & Trend Analysis

6. Immunohistochemistry: End-Use Estimates & Trend Analysis

7. Immunohistochemistry: Regional Estimates & Trend Analysis, by Product, Application, and End-use

8. Competitive Landscape

For more information about this report visit http://www.researchandmarkets.com/research/4vsx2h/immunohistochemist

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics